Bain Capital to acquire Tanabe Pharma in a carveout from Mitsubishi Chemical Group

The deal puts Tanabe Pharma at a valuation of about $3.3 billion.

7 February 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.